Product Information
CARTEOLOL HCL 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $1.3645 per ML under NDC 61314023810. Its NADAC has been published 462 times since Nov 28, 2013.
FDA first approved this application on Jan 3, 2000.
Strength
10 mg/mL
Manufacturer
Sandoz Inc.NDC
61314023810
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CARTEOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075476FDA Approved
1/3/2000
On Market Since
1/5/2000
Pharmacological Classes
Price Statistics
The NADAC for CARTEOLOL HCL 1% EYE DROPS has been published 462 times since Nov 28, 2013, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3645 per ML |
|---|---|
| All-time high | $1.7493 (May 15, 2024) |
| All-time low | $1.0044 (Mar 18, 2015) |
| 52-week high | $1.5705 |
| 52-week low | $1.3454 |
| Median price | $1.2918 |
| Average price | $1.2412 |
| Largest weekly change | +35.4% (Apr 17, 2024) |
| Weeks tracked | 462 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carteolol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARTEOLOL HCL 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for CARTEOLOL HCL 1% EYE DROPS, manufactured by Sandoz Inc., is $1.3645 per ML (NDC 61314023810), effective Sep 30, 2026.
How has the price of CARTEOLOL HCL 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for CARTEOLOL HCL 1% EYE DROPS has risen 15.5%. It has been tracked across 462 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARTEOLOL HCL 1% EYE DROPS?
Since Nov 28, 2013, the NADAC for CARTEOLOL HCL 1% EYE DROPS has ranged from a low of $1.0044 (Mar 18, 2015) to a high of $1.7493 (May 15, 2024), with a median of $1.2918 per ML.
Are there cheaper alternatives to CARTEOLOL HCL 1% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARTEOLOL HCL 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures CARTEOLOL HCL 1% EYE DROPS?
CARTEOLOL HCL 1% EYE DROPS (NDC 61314023810) is labeled by Sandoz Inc., and CMS classifies it as a generic product.